Pharmacotherapy 3 Flashcards

1
Q

Protein kinase inhibitors

A
Imatinib
Erlotinib
Sunitinib
Everolimus
Temisirolimus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Imatinib

A

Protein kinase inhibitor
GI tumors
CML

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Erlotinib

A

Protein kinase inhibitor

Metastasized NSCLC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Sunitinib

A

Protein kinase inhibitor
GI tumors
Hepatocellular carcinoma
Clear cell kidney carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Everolimus

A

Protein kinase inhibitor, mTOR-inhibitor

mediate- high risk metastatic renal cell cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Temisirolimus

A

Protein kinase inhibitor, mTOR-inhibitor

Low risk metastatic renal cell cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Bisphosphonates working

A

Attach to bone crystals > are absorbed by osteoclasts > induce apoptosis > freeze cycle of bone remodelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bisphosphonate medicine

A

Pamidronic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pamidronic acid

A

Bisphosphonate
Prevention of osteoporosis
Treatment of hypercalcemia
Metastases and mamma carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Low risk emesis

A

Metoclopramide

Dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Moderate risk emesis

A

5HT3-antagonist + dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Strong risk emesis

A

Predose of 5HT3-antagonist + dexamethasone

Then dexamethasone + metoclopramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Severe risk of emesis + cisplatin

A

Predose of 5HT3 antagonist + dexamethasone

Then dexametahsone + metoclopramide or aprepitant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly